Martin N. Gerding - Concepedia

Author

Martin N. Gerding

Amsterdam UMC Location University of Amsterdam

Also Known As

M Gerding, M N GERDING, M N Gerding, M. Gerding, M. N Gerding, M. N. Gerding, M.N Gerding, M.N. GERDING, M.N. Gerding, Martin Gerding

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam Deventer Ziekenhuis Rotterdam University of Applied Sciences Amsterdam University Medical Centers

About

Martin N. Gerding is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, ophthalmology, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	379
2	Immunology	2	2	130
3	Engineering	1	1	96
4	Nephrology	1	1	11
5	Pathology	1	1	11

Martin N. Gerding

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy Martin N. Gerding, Jolanda W. C. van der Meer, M. Broenink, Clinical Endocrinology	2000	321
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL Caroline B. Terwee, Martin N. Gerding, Friedo W. Dekker, British Journal of Ophthalmology	1998	301
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial Pieter F. de Groot, Silvia Pellegrini, Valeria Sordi, Gut	2020	297
A Randomized Controlled Trial of Orbital Radiotherapy<i>Versus</i>Sham Irradiation in Patients with Mild Graves’ Ophthalmopathy Mark F. Prummel, Caroline B. Terwee, Martin N. Gerding, The Journal of Clinical Endocrinology & Metabolism	2004	222
Quality of Life in Patients with Graves' Ophthalmopathy is Markedly Decreased: Measurement by the Medical Outcomes Study Instrument Martin N. Gerding, Caroline B. Terwee, Friedo W. Dekker, Thyroid Quality Of LifeLife AssessmentOcular DiseaseOphthalmologySevere Go	1997	219
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO‐QOL) after different treatments Caroline B. Terwee, Friedo W. Dekker, Maarten P. Mourits, Clinical Endocrinology	2001	201
Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy Iris M.M.J. Wakelkamp, Martin N. Gerding, J W C Van Der Meer, Clinical & Experimental Immunology Ocular DiseaseImmunologyImmunotherapyInflammationInflammatory Marker	2000	96
Test-Retest Reliability of the GO-QOL Caroline B. Terwee, Martin N. Gerding, Friedo W. Dekker, Journal of Clinical Epidemiology ReliabilityReliability EngineeringEngineeringTest-retest ReliabilitySoftware Testing	1999	96
Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy Martin N. Gerding, Friso M. van der Zant, Eric A. van Royen, Clinical Endocrinology	1999	85
Measuring disease activity to predict therapeutic outcome in Graves’ ophthalmopathy Caroline B. Terwee, Mark F. Prummel, Martin N. Gerding, Clinical Endocrinology	2005	82

Page 1